Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used to treat type 2 diabetes and sometimes obesity. GLP-1 RAs are very effective at lowering blood sugar levels.

An increasing number of people without diabetes are using GLP-1 agonist drugs for weight loss only. Image credit: MarkHatfield/Getty Images. This article originally appeared on Medical News Today.

The last few years have seen a marked increase in the use of glucagon-like peptide-1 receptor agonists (GLP-1 agonists) used for managing type 2 diabetes and as a way to lose weight.

Certain injectable diabetes drugs, ... Calibrate offers several GLP-1 medications for weight management, including Mounjaro. ... Iorga RA, et al. (2020).

Drug companies began developing GLP-1 drugs to treat diabetes in the early 1990s, and the first of them reached clinics in 2005. In 2014, the FDA approved their use to treat obesity.

GLP-1 RA medications safe and very effective for treating obesity in adults without diabetes Data also shows some very promising options that are not yet FDA approved Abstract: https://www ...

Now used for type 2 diabetes, new study shows GLP-1 drugs helped people with type 1 keep blood glucose levels in a healthy range while also losing weight. Skip to Main Content.

Recent research has explored the possibility of repurposing existing medications, typically used for other conditions, to address the challenges of SUD treatment. One such promising group of ...

Widely used GLP-1 drugs for type 2 diabetes such as Novo Nordisk's Ozempic may modestly reduce the risk of obesity-related cancers, especially colorectal cancer, according to data released on ...